Huntington's Disease: Neurodegeneration

Encyclopedia of Neuroscience

Volumn , Issue , 2009, Pages 39-44

  Chesselet, M F ^a   Hickey, M A ^a   Zhu, C ^a   Levine, M S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Aggregates; Apoptosis; Corticostriatal; Dark neurons; Glutamate; Huntington's disease; Knock in; Medium sized spiny neuron; Membrane; Mouse; Polyglutamine; Protein cleavage; Striatum; Transgenic

Indexed keywords

EID: 77952542216     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-008045046-9.00511-8     Document Type: Chapter

References (15)

1. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 2004, 431(7010):805-810.
2. Brouillet E., Conde F., Beal M.F., Hantraye P. Replicating Huntington's disease phenotype in experimental animals. Progress in Neurobiology 1999, 59(5):427-468.
3. Cattaneo E., Zuccato C., Tartari M. Normal huntingtin function: An alternative approach to Huntington's disease. Nature Reviews Neuroscience 2005, 6(12):919-930.
4. Cha J.H. Transcriptional dysregulation in Huntington's disease. Trends in Neurosciences 2000, 23(9):387-392.
5. DiFiglia M. Excitotoxic injury of the neostriatum: A model for Huntington's disease. Trends in Neurosciences 1990, 13(7):286-289.
6. Harper P.S. Huntington's Disease 1996, Saunders, London.
7. Hickey M.A., Chesselet M.F. Apoptosis in Huntington's disease. Progress in Neuropsychopharmacology and Biological Psychiatry 2003, 27(2):255-265.
8. Hickey M.A., Chesselet M.F. The use of transgenic and knock-in mice to study Huntington's disease. Cytogenetics and Genome Research 2003, 100(1-4):276-286.
9. Klapstein G.J., Fisher R.S., Zanjani H., et al. Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice. Journal of Neurophysiology 2001, 86(6):2667-2677.
10. Levine M.S., Cepeda C., Hickey M.A., Fleming S.M., Chesselet M.F. Genetic mouse models of Huntington's and Parkinson's diseases: Illuminating but imperfect. Trends in Neurosciences 2004, 27(11):691-697.
11. Mangiarini L., Sathasivam K., Seller M., et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87(3):493-506.
12. Menalled L.B. Knock-in mouse models of Huntington's disease. NeuroRx 2005, 2(3):465-470.
13. Menalled L.B., Chesselet M.F. Mouse models of Huntington's disease. Trends in Pharmacological Sciences 2002, 23(1):32-39.
14. Saudou F., Finkbeiner S., Devys D., Greenberg M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 1998, 95(1):55-66.
15. Vonsattel J.P., DiFiglia M. Huntington disease. Journal of Neuropathology and Experimental Neurology 1998, 57(5):369-384.